Triceps Strength Following Olecranon Fracture Fixation

November 15, 2026 updated by: Dr. Parham Daneshvar

A Randomized Controlled Trial Assessing Triceps Strength Following Olecranon Fracture Fixation Using a Triceps Tendon Sparing Plate vs Triceps Tendon Split Plate

The goal of this clinical trial is to compare two types of plates used to surgically treat olecranon fractures, which are fractures of the bony point of the elbow. The main questions it aims to answer are:

  • Does a plate that preserves the triceps tendon result in better triceps strength than a plate that requires splitting the triceps tendon?
  • Are there differences in elbow movement and function between the two treatments?

Researchers will compare participants treated with a short-flange plate that preserves the triceps tendon with participants treated with a long-flange plate that requires splitting the triceps tendon.

Participants will:

  • Be randomly assigned to one of the two surgical treatment groups
  • Undergo surgical fixation of their olecranon fracture using the assigned plate
  • Have their elbow strength and range of motion measured during follow-up
  • Complete questionnaires about arm function, elbow function, general health, and pain during follow-up

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Olecranon fractures are commonly treated with surgical plate fixation. Many standard olecranon plates have a long proximal flange that may require partial detachment or splitting of the triceps tendon insertion to allow appropriate plate placement. Short-flange plates can be used while preserving the triceps tendon insertion. The effect of these different fixation approaches on postoperative triceps strength and elbow function is not well established.

The objective of this randomized controlled trial is to compare short-flange plates that preserve the triceps tendon insertion with long-flange plates that require a triceps-splitting approach for fixation of olecranon fractures. The study will assess postoperative triceps strength, elbow range of motion, and functional outcomes. The investigators hypothesize that the triceps-sparing approach will result in better postoperative strength, range of motion, and function.

Participants will be randomized in a 1:1 ratio to one of two treatment groups. Group A will undergo open reduction and internal fixation using a short proximal flange plate with a triceps-sparing approach. Group B will undergo open reduction and internal fixation using a long proximal flange plate with a triceps-splitting approach.

The primary outcome is postoperative triceps strength, measured with a dynamometer at 1 year and 2 years after surgery. The secondary outcome is postoperative elbow range of motion, measured with a goniometer at 1 year and 2 years. Patient-reported outcomes will also be assessed at 1 year and 2 years using the QuickDASH, Mayo Elbow Score, Short Form-12 Physical and Mental Scores, and a Visual Analog Scale for pain.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ontario
      • Kingston, Ontario, Canada, K7L 2V7
        • Recruiting
        • Kingston Health Sciences Centre
        • Contact:
        • Contact:
        • Principal Investigator:
          • Parham Daneshvar, MD, FRCSC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 years or older
  • Isolated, acute, simple displaced olecranon fracture (Mayo Type 2-A)
  • Presenting for treatment at a participating study site

Exclusion Criteria:

  • Comminuted (multi-fragment) olecranon fracture
  • Polytrauma
  • Previous triceps injury
  • Previous olecranon fracture
  • Complication requiring reoperation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Triceps-Sparing Plate

Participants will undergo open reduction and internal fixation of the olecranon fracture using a short proximal flange plate with a triceps-sparing approach.

Participants will undergo open reduction and internal fixation of the olecranon fracture using a short proximal flange plate with a triceps-sparing approach.

Active Comparator: Triceps-Splitting Plate

Participants will undergo open reduction and internal fixation of the olecranon fracture using a long proximal flange plate with a triceps-splitting approach.

Participants will undergo open reduction and internal fixation of the olecranon fracture using a long proximal flange plate with a triceps-splitting approach.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Triceps Strength
Time Frame: 1 year and 2 years postoperatively

Triceps extension strength will be measured using a handheld digital dynamometer and recorded in Newtons. Strength will be assessed at fixed elbow positions, with measurements from the operated arm compared with the contralateral unaffected arm. The protocol identifies postoperative triceps strength as the primary outcome.

1 year and 2 years postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Elbow Range of Motion
Time Frame: 1 year and 2 years postoperatively

Elbow range of motion will be measured using a standard goniometer, including flexion, extension, pronation, and supination.

1 year and 2 years postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Parham Daneshvar, MD, FRCSC, Queen's University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2022

Primary Completion (Estimated)

August 1, 2030

Study Completion (Estimated)

February 1, 2031

Study Registration Dates

First Submitted

September 16, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 6032708

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the current study protocol does not include a plan for external sharing of participant-level data. Study data will be stored securely and accessed only by authorized study personnel.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.